Synthetic palm oil start-up raises $20m from Bill Gates-led fund
The financial backers for C16 Bioscience include also beauty investment specialists Waldencast
A synthetic palm oil manufacturer has raised US$20m in funding to scale its technology and prepare the business for commercial launch.
C16 Biosciences uses . . .
This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.
Or
Subscribe now to premium content on Cosmetics Business
Companies
